| vareniclinePREP:VARENICLINE |
HDGFL2 PWWP 1–93Homo sapiens |
KdNMR chemical-shift perturbation Kddirect binding affinity |
= 250 ± 40 µM250 µM · exact unit conversion |
Experimental context- Replicates
- Not curated
- Uncertainty definition
- fitting_error
- Temperature
- —
- Buffer
- HEPES-buffered saline; exact buffer/salt concentrations not restated in CSP subsection
- Conditions
- {"fit_model": "1:1 binding; global fit with shared Kd", "ligand_to_protein_molar_ratio_range": [0, 6], "protein_concentration_uM": 100, "protein_construct": "HDGFL2 1–93"}
- Qualification
- Full assay buffer, temperature and incubation metadata not transcribed; null means uncurated, not absent.
|
PMID:39031937 · 2024primary_publisher_selected_indexed_Results_and_Methods_passages; Figure S2 not independently retrievedOriginal observation record{
"DMSO_percent": null,
"abstract_reported_endpoint": null,
"abstract_reported_method": null,
"abstract_reported_units": null,
"abstract_reported_value": null,
"assay_construct_end": 93,
"assay_construct_start": 1,
"assay_record_id": "PWWP:ASSAY:0010",
"assay_type": "NMR chemical-shift perturbation Kd",
"assay_value_transferred_to_modeled_stereoisomers": 0,
"audit_decision": "retain_with_explicit_endpoint_and_identity",
"baseline_assay_record": 1,
"baseline_original": "{\"assay_record_id\": \"PWWP:ASSAY:0010\", \"assay_type\": \"NMR chemical-shift perturbation Kd\", \"ccd_id\": \"QMR\", \"ccd_mapping_source\": \"Provenance/Literature/ligand_ccd_associations.json\", \"compound_name\": \"varenicline\", \"conditions\": {}, \"domain\": \"PWWP\", \"evidence_location\": \"Results; Figure 1E\", \"evidence_url\": \"https://febs.onlinelibrary.wiley.com/doi/10.1002/1873-3468.14981\", \"gene\": \"HDGFL2\", \"interpretation\": \"Converted from 0.25 \u00b1 0.04 mM. Receptor pharmacology in other systems is not evidence of PWWP potency.\", \"numeric_value_inferred_from_structure\": false, \"pdb_id\": \"8Z6O\", \"reference_id\": \"PMID:39031937\", \"role\": \"experimentally_studied_fragment_ligand\", \"uncertainty\": 40, \"units\": \"\u00b5M\", \"value\": 250, \"value_operator\": \"=\", \"verification_level\": \"primary_full_text_sections_verified\"}",
"buffer": "HEPES-buffered saline; exact buffer/salt concentrations not restated in CSP subsection",
"ccd_id": "QMR",
"ccd_mapping_source": "Provenance/Literature/ligand_ccd_associations.json",
"chemical_id": "INCHIKEY:JQSHBVHOMNKWFT-DTORHVGOSA-N",
"chemical_identity_status": "exact_single_CCD_identity",
"component_context": null,
"compound_name": "varenicline",
"conditions": "{\"fit_model\": \"1:1 binding; global fit with shared Kd\", \"ligand_to_protein_molar_ratio_range\": [0, 6], \"protein_concentration_uM\": 100, \"protein_construct\": \"HDGFL2 1\u201393\"}",
"crystallographic_component_ids": null,
"domain": "PWWP",
"domain_id": "UP:Q7Z4V5:PWWP1",
"endpoint_label_status": null,
"evidence_class": "direct_binding_affinity",
"evidence_location": "Results; Figure 1E",
"evidence_url": "https://febs.onlinelibrary.wiley.com/doi/10.1002/1873-3468.14981",
"gene": "HDGFL2",
"interpretation": "Converted from 0.25 \u00b1 0.04 mM. Receptor pharmacology in other systems is not evidence of PWWP potency.",
"molecular_entity_type": "small_molecule_preparation",
"numeric_transcription_status": "matches_primary_report",
"numeric_value_inferred_from_structure": 0,
"pH": 7.4,
"pdb_id": "8Z6O",
"preparation_id": "PREP:VARENICLINE",
"protein_id": "UP:Q7Z4V5",
"qualitative_result": null,
"reference_id": "PMID:39031937",
"remaining_uncertainty": "Full assay buffer, temperature and incubation metadata not transcribed; null means uncurated, not absent.",
"replicates": null,
"role": "experimentally_studied_fragment_ligand",
"source_component_url": null,
"source_id": "S04",
"source_reported_uncertainty": "0.04",
"source_reported_units": "mM",
"source_reported_value": "0.25",
"source_verification_scope": "primary_publisher_selected_indexed_Results_and_Methods_passages; Figure S2 not independently retrieved",
"temperature_C": null,
"uncertainty": 40.0,
"uncertainty_type": "fitting_error",
"uncertainty_uM": 40.0,
"unit_conversion": "0.25 mM \u00d7 1000 = 250 \u00b5M; 0.04 mM \u00d7 1000 = 40 \u00b5M",
"units": "\u00b5M",
"value": 250.0,
"value_operator": "=",
"value_uM": 250.0,
"verification_level": "primary_full_text_sections_verified"
} |
| vareniclinePREP:VARENICLINE |
HDGFL2 PWWP1 1–93Variant: Y18SHomo sapiens |
KdNMR chemical-shift perturbation Kddirect binding affinity |
= 0.78 ± 0.05 mM780 µM · exact unit conversion |
Experimental context- Replicates
- Not curated
- Uncertainty definition
- fitting error
- Temperature
- °C
- Buffer
- Not curated
- Conditions
- {'binding_model': '1:1 global fit of perturbed residues', 'buffer': 'HEPES-buffered saline; CSP subsection does not separately give HEPES/NaCl concentrations', 'ligand_protein_molar_ratio_range': [0, 6], 'pH': 7.4, 'protein_concentration_mM': 0.1, 'target_variant': 'Y18S'}
- Qualification
- Y18S mutant measurement; must not be pooled with wild-type affinity. Construct is the source HDGFRP2 PWWP expression fragment (1–93) carrying the stated mutation. Replicate number and titration-specific temperature are not independently specified.
|
PMID:39031937 · 2024Official publisher full HTML independently inspected: Methods, Results and Figures 1–4 captions; original Supplementary Figure S2 was not retrievedOriginal observation record{
"assay_construct_end": 93,
"assay_construct_start": 1,
"assay_context": "purified_mutant_domain",
"assay_organism": "Homo sapiens",
"assay_record_id": "PWWP5:ASSAY:0027",
"assay_type": "NMR chemical-shift perturbation Kd",
"assay_value_transferred_to_modeled_stereoisomers": false,
"ccd_id": null,
"chemical_id": "INCHIKEY:JQSHBVHOMNKWFT-DTORHVGOSA-N",
"compound_name": "varenicline",
"conditions": {
"binding_model": "1:1 global fit of perturbed residues",
"buffer": "HEPES-buffered saline; CSP subsection does not separately give HEPES/NaCl concentrations",
"ligand_protein_molar_ratio_range": [
0,
6
],
"pH": 7.4,
"protein_concentration_mM": 0.1,
"target_variant": "Y18S"
},
"domain": "PWWP1",
"domain_id": "UP:Q7Z4V5:PWWP1",
"endpoint": "Kd",
"evidence_class": "direct_binding_affinity",
"evidence_location": "Results; Figure 2E",
"evidence_url": "https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1873-3468.14981",
"gene": "HDGFL2",
"inclusion_rationale": "Primary source explicitly identifies this preparation, target context and observation.",
"is_negative": false,
"numeric_transcription_status": "source_preserved",
"numeric_value_inferred_from_structure": false,
"pH": 7.4,
"pdb_id": null,
"preparation_id": "PREP:VARENICLINE",
"protein_id": "UP:Q7Z4V5",
"publication_year": 2024,
"reference_id": "PMID:39031937",
"remaining_uncertainty": "Y18S mutant measurement; must not be pooled with wild-type affinity. Construct is the source HDGFRP2 PWWP expression fragment (1\u201393) carrying the stated mutation. Replicate number and titration-specific temperature are not independently specified.",
"replicates": null,
"retrieval_date": "2026-10-26",
"role": "experimentally_studied_ligand",
"source_id": "P5:S:WEI2024",
"source_reported_uncertainty": "0.05",
"source_reported_units": "mM",
"source_reported_value": "0.78",
"source_verification_scope": "Official publisher full HTML independently inspected: Methods, Results and Figures 1\u20134 captions; original Supplementary Figure S2 was not retrieved",
"target_variant": "Y18S",
"uncertainty": 0.05,
"uncertainty_type": "fitting error",
"uncertainty_uM": 50.0,
"unit_conversion": "mM \u00d7 1000 = \u00b5M",
"units": "mM",
"value": 0.78,
"value_operator": "=",
"value_uM": 780.0,
"verification_level": "primary_source_verified",
"version": "phase5.chemical_curation.1.1.0"
} |